PROCEPT BioRobotics Corporation
Index- P/E- EPS (ttm)-1.56 Insider Own3.30% Shs Outstand44.32M Perf Week15.38%
Market Cap2.00B Forward P/E- EPS next Y-1.48 Insider Trans-46.30% Shs Float43.12M Perf Month6.83%
Income-68.80M PEG- EPS next Q-0.49 Inst Own80.70% Short Float5.80% Perf Quarter15.50%
Sales49.70M P/S40.27 EPS this Y-9.30% Inst Trans9.92% Short Ratio5.57 Perf Half Y79.55%
Book/sh5.40 P/B8.31 EPS next Y22.00% ROA-20.80% Target Price47.71 Perf Year-
Cash/sh6.05 P/C7.42 EPS next 5Y52.70% ROE-26.40% 52W Range15.38 - 47.73 Perf YTD79.41%
Dividend- P/FCF- EPS past 5Y- ROI-17.10% 52W High1.86% Beta-
Dividend %- Quick Ratio15.30 Sales past 5Y- Gross Margin50.20% 52W Low216.12% ATR2.55
Employees234 Current Ratio16.00 Sales Q/Q6.40% Oper. Margin- RSI (14)69.95 Volatility6.32% 5.55%
OptionableYes Debt/Eq0.21 EPS Q/Q33.20% Profit Margin- Rel Volume1.81 Prev Close44.87
ShortableYes LT Debt/Eq0.21 EarningsAug 04 AMC Payout- Avg Volume449.63K Price48.62
Recom2.00 SMA2014.22% SMA5026.65% SMA20050.58% Volume161,727 Change8.36%
Sep-02-22Initiated Wells Fargo Overweight $49
Jul-15-22Initiated KeyBanc Capital Markets Overweight $47
Jun-23-22Initiated B. Riley Securities Buy $53
Oct-11-21Initiated SVB Leerink Outperform $46
Oct-11-21Initiated Guggenheim Buy $45
Oct-11-21Initiated Goldman Neutral $37
Oct-11-21Initiated Cowen Outperform $50
Oct-11-21Initiated BofA Securities Buy $48
Aug-22-22 04:03PM  
Aug-05-22 05:30PM  
Aug-04-22 04:03PM  
Jul-14-22 04:02PM  
Jul-10-22 08:32AM  
Jun-16-22 02:30PM  
Jun-09-22 09:01AM  
May-10-22 06:20AM  
May-05-22 04:02PM  
Apr-28-22 08:00AM  
Apr-12-22 04:02PM  
Apr-11-22 08:00AM  
Mar-10-22 06:03AM  
Mar-08-22 04:00PM  
Feb-22-22 08:00AM  
Feb-14-22 04:03PM  
Feb-01-22 04:03PM  
Jan-31-22 01:38PM  
Jan-18-22 10:11AM  
Jan-14-22 12:37PM  
Jan-11-22 04:03PM  
Jan-06-22 10:18AM  
Jan-04-22 07:00AM  
Dec-15-21 08:04AM  
Dec-14-21 05:38PM  
Nov-05-21 12:01PM  
Nov-04-21 04:03PM  
Oct-26-21 07:00AM  
Oct-21-21 04:04PM  
Sep-28-21 07:00AM  
Sep-21-21 04:05PM  
Sep-17-21 05:28AM  
Sep-15-21 12:12PM  
Sep-14-21 07:03PM  
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Krummel Thomas MDirectorJun 22Option Exercise4.512,68912,134102,920Jun 22 07:11 PM
Krummel Thomas MDirectorJun 21Option Exercise2.5917,31144,773100,231Jun 22 07:11 PM
Krummel Thomas MDirectorJun 21Sale35.9820,000719,65382,920Jun 22 07:11 PM
Nouri AlalehEVP, CLO, CORP. SEC.May 16Sale35.0667823,77146,468May 16 05:49 PM
VIKING GLOBAL INVESTORS LP10% OwnerMar 18Sale29.901,249,00037,345,100298,205Mar 22 08:51 PM
Wood Morgan ColbyDirectorMar 11Buy24.4394022,961147,713Mar 14 05:01 PM